Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | MAOB | P27338 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.45 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29797921 | 1.00 | MAOA (0.58) | MAOAMAOBATMMEN1KMT2A | |
| SCHEMBL10692504 | 0.86 | MAOA (0.45) | MAOAMAOBATMMEN1KMT2A | |
| SCHEMBL12205445 | 0.84 | KMT2A (0.46) | MAOAMAOBATMMEN1KMT2A | |
| SCHEMBL10967593 | 0.83 | MAOA (0.46) | MAOAMAOBATMMEN1KMT2A | |
| SCHEMBL31545095 | 0.82 | MEN1 (0.48) | MAOAMAOBATMMEN1KMT2A | |
| SCHEMBL12891380 | 0.81 | MAOA (0.45) | MAOAMAOBATMMEN1KMT2A | |
| SCHEMBL29767372 | 0.81 | MAOA (0.45) | MAOAMAOBATMMEN1KMT2A | |
| SCHEMBL2407012 | 0.81 | MAOA (0.45) | MAOAMAOBATMMEN1KMT2A | |
| SCHEMBL29473842 | 0.81 | MAOA (0.45) | MAOAMAOBATMMEN1KMT2A | |
| SCHEMBL15147092 | 0.81 | MAOA (0.45) | MAOAMAOBATMMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117551069-B | Near-infrared methyl xanthene dye and preparation method and application thereof | 临沂大学 | 2025-03-04 | — | — | CN | claimed |
| CN-117551069-A | Near-infrared methyl xanthene dye and preparation method and application thereof | 临沂大学 | 2024-02-13 | — | — | CN | claimed |
| CN-109879713-A | A kind of preparation method of trans- four substituted olefines derivative | 华侨大学 | 2019-06-14 | — | — | CN | claimed |
| US-8030096-B2 | Water-soluble rhodamine dyes conjugates | APPLIED BIOSYSTEMS LLC (US) | 2011-10-04 | — | — | US | claimed |
| US-20110081688-A1 | Water-Soluble Rhodamine Dyes Conjugates | Life Technologies Corporation (US) | 2011-04-07 | — | — | US | claimed |
| US-7795042-B2 | Water-soluble rhodamine dye conjugates | APPLIED BIOSYSTEMS, LLC (US) | 2010-09-14 | — | — | US | claimed |
| US-20090305433-A1 | Water-Soluble Rhodamine Dye Conjugates | APPLIED BIOSYSTEMS INC. (US) | 2009-12-10 | — | — | US | claimed |
| US-7504496-B2 | Water-soluble rhodamine dye conjugates | APPLIED BIOSYSTEMS, LLC | 2009-03-17 | — | — | US | claimed |
| US-20070077222-A1 | Composition and treatment for hair loss | RETAINE PRODUCTS, LLC. | 2007-04-05 | — | — | US | claimed |
| JP-3719979-B2 | — | — | 2005-11-24 | — | — | JP | claimed |
| EP-0771196-A4 | EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS | LILLY CO ELI (US) | 1997-09-03 | — | — | EP | claimed |
| WO-1997025351-A2 | INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR | LEUKOSITE, INC. (US) | 1997-07-17 | — | — | WO | claimed |
| EP-0771196-A1 | EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1997-05-07 | — | — | EP | claimed |
| US-5614550-A | ANTICHOLESTEROL AGENTS OR ARTERIOSCLEROSIS AGENTS FOR HUMANS | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | claimed |
| US-5534529-A | Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-09 | — | — | US | claimed |
| WO-1996007405-A1 | EXCITATORY AMINO ACID RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 1996-03-14 | — | — | WO | claimed |
| EP-0632036-A2 | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1995-01-04 | — | — | EP | claimed |
| US-5227560-A | Vinylene or exomethylene groups from active methine compounds | THE DOW CHEMICAL COMPANY (US) | 1993-07-13 | — | — | US | claimed |
| US-5101059-A | Xanthene compounds | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1992-03-31 | — | — | US | claimed |
| WO-1991008190-A1 | AMINO ACID PROTECTING GROUPS | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-06-13 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090305433-A1 | Water-Soluble Rhodamine Dye Conjugates | SLC43A3, ABCG2, TARBP1 | MAOA 4751/4885MAOB 4447/4885ATM 4074/4885 |
| US-20110081688-A1 | Water-Soluble Rhodamine Dyes Conjugates | SLC43A3, ABCG2, TARBP1 | MAOA 4751/4885MAOB 4416/4885ATM 3999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.